Methylation Status of Genes Upregulated by Demethylating Agent 5-aza-2′-Deoxycytidine in Hepatocellular Carcinoma

Yuichi Hirasawa(Chiba University), Osamu Yokosuka(Chiba University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Kenichi Fukai(Chiba University), Fumio Imazeki(Chiba University), Hiromitsu Saisho(Chiba University), Rintaro Mikata, Masaru Miyazaki(NTT (Japan)), Takenori Ochiai(Chiba University), Motohisa Tada(Chiba University)
Oncology
January 1, 2006
10.1159/000100475
Cited by 74

Related Papers

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|720
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|300